Suppr超能文献

用于镰状细胞病耐力运动处方的生理评估。

Physiological Evaluation for Endurance Exercise Prescription in Sickle Cell Disease.

机构信息

University Savoie Mont Blanc, Inter-university Laboratory of Human Movement Sciences, Chambéry EA7424, FRANCE.

Department of Cardiac Rehabilitation, Henri-Mondor University Hospital, AP-HP, Creteil, FRANCE.

出版信息

Med Sci Sports Exerc. 2019 Sep;51(9):1795-1801. doi: 10.1249/MSS.0000000000001993.

Abstract

PURPOSE

Although strenuous exercise may expose sickle cell disease (SCD) patients to risks of vaso-occlusive crisis, evidence suggests that regular endurance exercise may be beneficial. This study aimed to test (i) the safety and usefulness of a submaximal incremental exercise in evaluating physical ability of SCD patients and identify a marker for the management of endurance exercise and (ii) the feasibility of endurance exercise sessions in SCD patients.

METHODS

Twenty adults with SCD (12 men and 8 women) performed a submaximal incremental exercise used to determine the first lactate threshold (LT1) and stopped as soon as blood lactate concentration ([lactate]b) reached ≥4 mmol·L. Fifteen of those patients (8 men and 7 women) also performed three 30-min endurance exercise sessions at ~2.5 mmol·L of [lactate]b on separate occasions.

RESULTS

LT1 occurred at 47 ± 3 and 33 ± 3 W for men and women, respectively, demonstrating the extreme deconditioning and, thus, low physical ability of adult SCD patients. During endurance exercise, peripheral oxygen saturation and [lactate]b most often remained stable and within acceptable ranges.

CONCLUSIONS

The proposed strategy of submaximal incremental exercise allowed safe determination of LT1, an important parameter of patients' physical ability. The study also demonstrated the feasibility and safety of individually tailored endurance exercises at ~2.5 mmol·L of [lactate]b. These latter results suggest that endurance training programs may be considered for adult SCD patients and that the method proposed here may be helpful in that regard.

摘要

目的

尽管剧烈运动可能使镰状细胞病(SCD)患者面临血管阻塞性危象的风险,但有证据表明,定期耐力运动可能是有益的。本研究旨在测试:(i)亚最大增量运动在评估 SCD 患者身体能力方面的安全性和有用性,并确定耐力运动管理的标志物;(ii)SCD 患者进行耐力运动的可行性。

方法

20 名成年 SCD 患者(12 名男性和 8 名女性)进行了亚最大增量运动,用于确定第一乳酸阈(LT1),并在血乳酸浓度([lactate]b)达到≥4 mmol·L 时立即停止。其中 15 名患者(8 名男性和 7 名女性)还在另外三个不同的场合,以~2.5 mmol·L 的 [lactate]b 进行了三次 30 分钟的耐力运动。

结果

男性和女性的 LT1 分别出现在 47 ± 3 和 33 ± 3 W,表明成年 SCD 患者的身体能力极度受限,因此状态极差。在耐力运动期间,外周血氧饱和度和 [lactate]b 通常保持稳定并处于可接受的范围内。

结论

所提出的亚最大增量运动策略允许安全地确定 LT1,这是患者身体能力的一个重要参数。该研究还表明,以~2.5 mmol·L 的 [lactate]b 进行个体化定制的耐力运动是可行且安全的。这些结果表明,耐力训练计划可能会被考虑用于成年 SCD 患者,并且这里提出的方法可能会对此有所帮助。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验